AAAAAA
Results: 1-25/42
Authors:
Mossner, R
Henneberg, A
Schmitt, A
Syagailo, YV
Grassle, M
Hennig, T
Simantov, R
Gerlach, M
Riederer, P
Lesch, KP
Citation: R. Mossner et al., Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease, MOL PSYCHI, 6(3), 2001, pp. 350-352
Authors:
Harth, R
Gerlach, M
Riederer, P
Gotz, ME
Citation: R. Harth et al., A highly sensitive method for the determination of protein bound 3,4-dihydroxyphenylalanine as a marker for post-translational protein hydroxylation in human tissues ex vivo, FREE RAD RE, 35(2), 2001, pp. 167-174
Authors:
Gerlach, M
Blum-Degen, D
Ransmayr, G
Leblhuber, F
Pedersen, V
Riederer, P
Citation: M. Gerlach et al., Expression, but not activity, of neuronal nitric oxide synthase is regionally increased in the alcoholic brain, ALC ALCOHOL, 36(1), 2001, pp. 65-69
Authors:
Kupsch, A
Sautter, J
Gotz, ME
Breithaupt, W
Schwarz, J
Youdim, MBH
Riederer, P
Gerlach, M
Oertel, WH
Citation: A. Kupsch et al., Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline, J NEURAL TR, 108(8-9), 2001, pp. 985-1009
Authors:
Gerlach, M
Xiao, AY
Kuhn, W
Lehnfeld, R
Waldmeier, P
Sontag, KH
Riederer, P
Citation: M. Gerlach et al., The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats, J NEURAL TR, 108(2), 2001, pp. 189-204
Authors:
Gotz, ME
Janetzky, B
Pohli, S
Gottschalk, A
Gsell, W
Tatschner, T
Ransmayr, G
Leblhuber, F
Gerlach, M
Reichmann, H
Riederer, P
Boning, J
Citation: Me. Gotz et al., Chronic alcohol consumption and cerebral indices of oxidative stress: Is there a link?, ALC CLIN EX, 25(5), 2001, pp. 717-725
Authors:
Berg, D
Gerlach, M
Youdim, MBH
Double, KL
Zecca, L
Riederer, P
Becker, G
Citation: D. Berg et al., Brain iron pathways and their relevance to Parkinson's disease, J NEUROCHEM, 79(2), 2001, pp. 225-236
Authors:
Zecca, L
Gallorini, M
Schunemann, V
Trautwein, AX
Gerlach, M
Riederer, P
Vezzoni, P
Tampellini, D
Citation: L. Zecca et al., Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes, J NEUROCHEM, 76(6), 2001, pp. 1766-1773
Authors:
Koutsilieri, E
Scheller, C
Sopper, S
Gotz, ME
Gerlach, M
ter Meulen, V
Riederer, P
Citation: E. Koutsilieri et al., Selegiline completely restores choline acetyltransferase activity deficitsin simian immunodeficiency infection, EUR J PHARM, 411(1-2), 2001, pp. R1-R2
Authors:
Ibarra, C
Nedvetsky, PI
Gerlach, M
Riederer, P
Schmidt, HHHW
Citation: C. Ibarra et al., Regional and age-dependent expression of the nitric oxide receptor, soluble guanylyl cyclase, in the human brain, BRAIN RES, 907(1-2), 2001, pp. 54-60
Authors:
Czub, S
Koutsilieri, E
Sopper, S
Czub, M
Stahl-Hennig, C
Muller, JG
Pedersen, V
Gsell, W
Heeney, JL
Gerlach, M
Gosztonyi, G
Riederer, P
ter Meulen, V
Citation: S. Czub et al., Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs, ACT NEUROP, 101(2), 2001, pp. 85-91
Authors:
Spielmann, S
Kerner, T
Ahlers, O
Keh, D
Gerlach, M
Gerlach, H
Citation: S. Spielmann et al., Early detection of increased tumour necrosis factor alpha (TNF alpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course, ACT ANAE SC, 45(3), 2001, pp. 364-370
Authors:
Foley, P
Gerlach, M
Youdim, MBH
Riederer, P
Citation: P. Foley et al., MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?, PARKINS R D, 6(1), 2000, pp. 25-47
Authors:
Heim, C
Zhang, JJ
Lan, J
Sieklucka, M
Kurz, T
Riederer, P
Gerlach, M
Sontag, KH
Citation: C. Heim et al., Cerebral oligaemia episode triggers free radical formation and late cognitive deficiencies, EUR J NEURO, 12(2), 2000, pp. 715-725
Authors:
Ford, RM
Robson, C
Temple, D
Gerlach, M
Citation: Rm. Ford et al., Metrics for shot boundary detection in digital video sequences, MULTIMEDI S, 8(1), 2000, pp. 37-46
Authors:
Gerlach, M
Riederer, P
Reichmann, H
Citation: M. Gerlach et al., Preclinical and clinical aspects of dopamine agonists. What is known for certain?, NERVENHEILK, 19(2), 2000, pp. 53
Authors:
Riederer, P
Sian, J
Gerlach, M
Citation: P. Riederer et al., Is there neuroprotection in Parkinson syndrome?, J NEUROL, 247, 2000, pp. 8-11
Authors:
Xiao, AY
Double, K
Heinemann, T
Rausch, WD
Riederer, P
Gerlach, M
Citation: Ay. Xiao et al., The industrial chemical Tinuvin 123 does not induce dopaminergic neurotoxicity in C57BI/6 mice, NEUROSCI L, 278(3), 2000, pp. 165-168
Authors:
Gotz, ME
Gerstner, A
Harth, R
Dirr, A
Janetzky, B
Kuhn, W
Riederer, P
Gerlach, M
Citation: Me. Gotz et al., Altered redox state of platelet coenzyme Q(10) in Parkinson's disease, J NEURAL TR, 107(1), 2000, pp. 41-48
Authors:
Kuhn, W
Muller, T
Kraus, PH
Gerlach, M
Citation: W. Kuhn et al., Parkinson's disease: Progress in neurodegenerative and clinical research -Foreword, J NEURAL TR, 107(1), 2000, pp. I-I
Authors:
Double, KL
Zecca, L
Costi, P
Mauer, M
Griesinger, C
Ito, S
Ben-Shachar, D
Bringmann, G
Fariello, RG
Riederer, P
Gerlach, M
Citation: Kl. Double et al., Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins, J NEUROCHEM, 75(6), 2000, pp. 2583-2589
Authors:
Double, KL
Zecca, L
Ben-Shachar, D
Youdim, MBH
Riederer, P
Gerlach, M
Citation: Kl. Double et al., Neuromelanin may mediate neurotoxicity via its interaction with redox active iron, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 211-218
Authors:
Gerlach, M
Youdim, MBH
Riederer, P
Citation: M. Gerlach et al., Brain iron and other trace metals in neurodegenerative diseases, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 259-276
Authors:
Reggelin, M
Gerlach, M
Vogt, M
Citation: M. Reggelin et al., Metallated 2-alkenyl sulfoximines in asymmetric synthesis: Regio- and stereoselective synthesis of highly substituted oxabicyclic ethers and studies towards the total syntheses of the euglobals G1 and G2 and arenaran A, EUR J ORG C, (5), 1999, pp. 1011-1031
Authors:
Czub, M
Czub, S
Gosztonyi, G
Koutsilieri, E
Sopper, S
Muller, JG
Gerlach, M
Riederer, P
ter Meulen, V
Citation: M. Czub et al., Effects of Selegiline in a retroviral rat model for neurodegenerative disease, J NEUROVIRO, 5(5), 1999, pp. 458-464